2025 Q4 -tulosraportti
90 päivää sitten
‧1 t 12 min
7,95 DKK/osake
Viimeisin osinko
4,14%Tuotto/v
Tarjoustasot
Nasdaq Copenhagen
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 112 | - | - | ||
| 112 | - | - | ||
| 112 | - | - | ||
| 112 | - | - | ||
| 112 | - | - |
Välittäjätilasto
Dataa ei löytynyt
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q1 -tulosraportti 6.5. | Tänään |
| Menneet tapahtumat | ||
|---|---|---|
Vuosittainen yhtiökokous 2026 26.3. | ||
2025 Q4 -tulosraportti 4.2. | ||
Ylimääräinen yhtiökokous 2025 14.11.2025 | ||
2025 Q3 -tulosraportti 5.11.2025 | ||
2025 Q2 -tulosraportti 6.8.2025 |
Asiakkaat katsoivat myös
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
·2 t sittenTomorrow morning around 07:32 AM, you can try to take the pulse of our dear Novo. Log on to chat.mistral.ai, chatgpt or deepseek. Prompt: Show NVO (NYSE) revenue, net income, net profit margin, EPS, EBITDA for Q1 2026: expected vs reported, with beat/miss in %. Use a table. *****Data: https://www.google.com/finance/quote/NVO:NYSEhttps://www.novonordisk.com/investors/financial-results.html Nvo currently costs at 22:29 286,60kr over in Benneweis City ;-) Good luck & Good night.
·1 t sittenThanks for the advice. I don't get any of those numbers, so I'll just drink a coffee and eat a cinnamon bun and hope it's at 500+ in 5 years.·40 min sittenThat's one way to do it too. If you own shares in value companies and bought before they reached all-time, then it's a good strategy. Buy shares in many value companies, especially those that pay dividends, and reinvest dividends, then you will become rich in the long run.
·3 t sittenRises a bit in aftermarket….
·2 t sittenNo, down in after-hours trading in US.
·3 t sitten · MuokattuIs it not a bit pathetic to see a couple of analysts trying to stick to their story that Lilly should cost $1400 USD and Novo has lost growth forever? "ELI LILLY: JEFFERIES PREDICTS BOOST FOR FUNDAYO IN MID-MAY" Ohh - Mid-May. THAT's when it happens. Right. "Deloitte warns of 'bubble' in the pharmaceutical sector" Ok - So now there's suddenly a bubble right ahead? "Novo gets target price raised by ABG to 230 kr." Yeah ok, the price is almost 50% above your previous useless predictions anyway. We'd better give a little, so we don't look too amateurish. The hour of truth tomorrow. I wonder if the price will open above 300 kroner. That's my guess. The most important thing was to avoid disappointing and downgrading again. They probably won't do that either. The market has anticipated the good news a bit, but I don't think it's finished at all.
·1 t sitten · MuokattuThe price targets of American analysts have never been reliable.. They are mostly pro-America and often have a hidden agenda behind the price targets they set. In some cases, it can seem like the analysis is a commissioned product. They omit significant facts that are unfavorable to their analyses and hype up the positive. I have read in several places that Foundayo has had a good start, which is outright wrong. That there is friction with birth control pills is a huge blocker for a large proportion of potential customers. Not mentioned or only mentioned in a side note.
·4 t sittenTomorrow we might find out if we are going to have the possibly last leg down or if we are going to go up and test 400 again. Will be exciting :-)
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
2025 Q4 -tulosraportti
90 päivää sitten
‧1 t 12 min
7,95 DKK/osake
Viimeisin osinko
4,14%Tuotto/v
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
- ·2 t sittenTomorrow morning around 07:32 AM, you can try to take the pulse of our dear Novo. Log on to chat.mistral.ai, chatgpt or deepseek. Prompt: Show NVO (NYSE) revenue, net income, net profit margin, EPS, EBITDA for Q1 2026: expected vs reported, with beat/miss in %. Use a table. *****Data: https://www.google.com/finance/quote/NVO:NYSEhttps://www.novonordisk.com/investors/financial-results.html Nvo currently costs at 22:29 286,60kr over in Benneweis City ;-) Good luck & Good night.·1 t sittenThanks for the advice. I don't get any of those numbers, so I'll just drink a coffee and eat a cinnamon bun and hope it's at 500+ in 5 years.·40 min sittenThat's one way to do it too. If you own shares in value companies and bought before they reached all-time, then it's a good strategy. Buy shares in many value companies, especially those that pay dividends, and reinvest dividends, then you will become rich in the long run.
- ·3 t sittenRises a bit in aftermarket….·2 t sittenNo, down in after-hours trading in US.
- ·3 t sitten · MuokattuIs it not a bit pathetic to see a couple of analysts trying to stick to their story that Lilly should cost $1400 USD and Novo has lost growth forever? "ELI LILLY: JEFFERIES PREDICTS BOOST FOR FUNDAYO IN MID-MAY" Ohh - Mid-May. THAT's when it happens. Right. "Deloitte warns of 'bubble' in the pharmaceutical sector" Ok - So now there's suddenly a bubble right ahead? "Novo gets target price raised by ABG to 230 kr." Yeah ok, the price is almost 50% above your previous useless predictions anyway. We'd better give a little, so we don't look too amateurish. The hour of truth tomorrow. I wonder if the price will open above 300 kroner. That's my guess. The most important thing was to avoid disappointing and downgrading again. They probably won't do that either. The market has anticipated the good news a bit, but I don't think it's finished at all.·1 t sitten · MuokattuThe price targets of American analysts have never been reliable.. They are mostly pro-America and often have a hidden agenda behind the price targets they set. In some cases, it can seem like the analysis is a commissioned product. They omit significant facts that are unfavorable to their analyses and hype up the positive. I have read in several places that Foundayo has had a good start, which is outright wrong. That there is friction with birth control pills is a huge blocker for a large proportion of potential customers. Not mentioned or only mentioned in a side note.
- ·4 t sittenTomorrow we might find out if we are going to have the possibly last leg down or if we are going to go up and test 400 again. Will be exciting :-)
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Nasdaq Copenhagen
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 112 | - | - | ||
| 112 | - | - | ||
| 112 | - | - | ||
| 112 | - | - | ||
| 112 | - | - |
Välittäjätilasto
Dataa ei löytynyt
Asiakkaat katsoivat myös
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q1 -tulosraportti 6.5. | Tänään |
| Menneet tapahtumat | ||
|---|---|---|
Vuosittainen yhtiökokous 2026 26.3. | ||
2025 Q4 -tulosraportti 4.2. | ||
Ylimääräinen yhtiökokous 2025 14.11.2025 | ||
2025 Q3 -tulosraportti 5.11.2025 | ||
2025 Q2 -tulosraportti 6.8.2025 |
2025 Q4 -tulosraportti
90 päivää sitten
‧1 t 12 min
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q1 -tulosraportti 6.5. | Tänään |
| Menneet tapahtumat | ||
|---|---|---|
Vuosittainen yhtiökokous 2026 26.3. | ||
2025 Q4 -tulosraportti 4.2. | ||
Ylimääräinen yhtiökokous 2025 14.11.2025 | ||
2025 Q3 -tulosraportti 5.11.2025 | ||
2025 Q2 -tulosraportti 6.8.2025 |
7,95 DKK/osake
Viimeisin osinko
4,14%Tuotto/v
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
- ·2 t sittenTomorrow morning around 07:32 AM, you can try to take the pulse of our dear Novo. Log on to chat.mistral.ai, chatgpt or deepseek. Prompt: Show NVO (NYSE) revenue, net income, net profit margin, EPS, EBITDA for Q1 2026: expected vs reported, with beat/miss in %. Use a table. *****Data: https://www.google.com/finance/quote/NVO:NYSEhttps://www.novonordisk.com/investors/financial-results.html Nvo currently costs at 22:29 286,60kr over in Benneweis City ;-) Good luck & Good night.·1 t sittenThanks for the advice. I don't get any of those numbers, so I'll just drink a coffee and eat a cinnamon bun and hope it's at 500+ in 5 years.·40 min sittenThat's one way to do it too. If you own shares in value companies and bought before they reached all-time, then it's a good strategy. Buy shares in many value companies, especially those that pay dividends, and reinvest dividends, then you will become rich in the long run.
- ·3 t sittenRises a bit in aftermarket….·2 t sittenNo, down in after-hours trading in US.
- ·3 t sitten · MuokattuIs it not a bit pathetic to see a couple of analysts trying to stick to their story that Lilly should cost $1400 USD and Novo has lost growth forever? "ELI LILLY: JEFFERIES PREDICTS BOOST FOR FUNDAYO IN MID-MAY" Ohh - Mid-May. THAT's when it happens. Right. "Deloitte warns of 'bubble' in the pharmaceutical sector" Ok - So now there's suddenly a bubble right ahead? "Novo gets target price raised by ABG to 230 kr." Yeah ok, the price is almost 50% above your previous useless predictions anyway. We'd better give a little, so we don't look too amateurish. The hour of truth tomorrow. I wonder if the price will open above 300 kroner. That's my guess. The most important thing was to avoid disappointing and downgrading again. They probably won't do that either. The market has anticipated the good news a bit, but I don't think it's finished at all.·1 t sitten · MuokattuThe price targets of American analysts have never been reliable.. They are mostly pro-America and often have a hidden agenda behind the price targets they set. In some cases, it can seem like the analysis is a commissioned product. They omit significant facts that are unfavorable to their analyses and hype up the positive. I have read in several places that Foundayo has had a good start, which is outright wrong. That there is friction with birth control pills is a huge blocker for a large proportion of potential customers. Not mentioned or only mentioned in a side note.
- ·4 t sittenTomorrow we might find out if we are going to have the possibly last leg down or if we are going to go up and test 400 again. Will be exciting :-)
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Nasdaq Copenhagen
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 112 | - | - | ||
| 112 | - | - | ||
| 112 | - | - | ||
| 112 | - | - | ||
| 112 | - | - |
Välittäjätilasto
Dataa ei löytynyt